Gyon Technologies Capital Management, LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
Gyon Technologies Capital Management, LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$457,000
-44.3%
13,199
-52.9%
0.32%
+113.2%
Q4 2021$820,00028,0120.15%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 383,702$14,581,0007.71%
Perceptive Advisors 5,148,910$195,658,0005.23%
Grace Capital 312,514$11,876,0004.65%
NEXTHERA CAPITAL LP 549,231$20,871,0004.00%
Asymmetry Capital Management, L.P. 103,449$3,931,0003.63%
Camber Capital Management LP 2,075,000$78,850,0003.37%
Casdin Capital, LLC 440,000$16,720,0002.03%
EMORY UNIVERSITY 53,951$2,050,0001.34%
ArchPoint Investors 129,435$4,919,0001.34%
Ghost Tree Capital, LLC 150,000$5,700,0001.21%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders